GlassScriptPhysician profile
Harvey A Sauer
NPI 1891889390
$10,746.86
in general payments reported to CMS, 2019-2025
38 companies · $924 in 2025
The $924 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $6,331 · 2021: $688 · 2022: $833 · 2023: $847 · 2024: $631 · 2025: $924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,366 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,366.08 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,000.00 | 2020 | |
| Astellas Pharma US INC | $763.81 | 2019-2024 | Myrbetriq, Veozah |
| Abbvie INC. | $239.27 | 2019-2025 | Botox |
| Bayer Healthcare Pharmaceuticals INC. | $225.12 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $220.58 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Urogen Pharma, INC. | $210.53 | 2021-2024 | Jelmyto |
| Coloplast Corp | $185.82 | 2023-2025 | Speedicath, Altis |
| 180 Medical, INC. | $179.90 | 2019-2024 | Gentlecath Glide, Gentlecath, Lofric |
| Urovant Sciences INC | $177.20 | 2021-2022 | |
| Tolmar, INC. | $160.19 | 2023-2025 | Jatenzo, Eligard |
| Pfizer INC. | $159.81 | 2019-2023 | |
| Myriad Genetic Laboratories, INC. | $159.70 | 2021-2023 | Prolaris, Myrisk |
| Amgen INC. | $149.51 | 2019-2022 | |
| Accord Healthcare, INC. | $147.78 | 2023-2024 | |
| Histosonics, INC. | $142.42 | 2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $140.39 | 2025 | |
| Procept Biorobotics Corporation | $135.75 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $128.81 | 2019-2022 | |
| Myovant Sciences INC. | $100.96 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $95.05 | 2019-2024 | Provenge |
| Axonics, INC. | $92.40 | 2024 | Bulkamid, Axonics |
| Antares Pharma, INC. | $90.44 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $87.87 | 2023-2024 | Orgovyx, Gemtesa |
| Verity Pharmaceuticals INC. | $81.49 | 2025 | Trelstar |
| Teleflex LLC | $79.79 | 2022-2024 | Urolift |
| Janssen Biotech, INC. | $73.02 | 2025 | Erleada |
| Olympus America INC. | $68.25 | 2023-2025 | Itind System |
| Blue Earth Diagnostics | $66.45 | 2021-2023 | |
| Dentsply Ih Ab | $64.19 | 2025 | Lofric |
| Neotract INC. | $60.45 | 2020 | |
| Clarus Therapeutics INC. | $55.65 | 2021 | |
| Dentsply Ih INC. | $48.75 | 2022 | |
| Endo Pharmaceuticals INC. | $39.19 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Laborie Medical Technologies Corp. | $27.89 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Immunitybio, INC. | $22.46 | 2024 | |
| Allergan, INC. | $18.72 | 2021 | |
| Cook Medical LLC | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Sauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.